West Pharmaceutical Services (WST) Return on Assets (2010 - 2026)

West Pharmaceutical Services (WST) has reported Return on Assets for 17 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Assets improved to 0.0% in Q2 2026 per WST's latest filing, from 0.0% in the prior quarter.
• Over the last five years, Return on Assets for WST reached as high as 0.0% in Q1 2022 and fell as low as 0.0% in Q4 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
• The largest YoY upside for Return on Assets was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
• Year by year, Return on Assets stood at 0.0% in 2022, then decreased by 7 bps to 0.0% in 2023, then retreated by 14 bps to 0.0% in 2024, then decreased by 12 bps to 0.0% in 2025, then rose by 17 bps to 0.0% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.